Delving into the Latest Updates on Beijing Danqing Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Urogenital Diseases

Digestive System Disorders

Small molecule drug

Chemical drugs

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	9
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	7
Chemical drugs	2
Unknown	1

Top 5 Target	Count

PARG(Poly(ADP-ribose) glycohydrolase)	3
POLQ(DNA polymerase theta)	3
WRN(WRN RecQ like helicase)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Sep 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

5

1

IND Application

Phase 1

2

1

Phase 2

Phase 3

1

2

Other

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

DAT-2000 ( PARG )	Female Genital Neoplasms More	Phase 2/3
DAT-1604 ( POLQ )	Advanced Malignant Solid Neoplasm More	Phase 1
DAT-1000 ( POLQ )	Female Genital Neoplasms More	Phase 1
DAT-2645 ( PARG )	BRCA-Mutated Malignant Neoplasm More	IND Approval
DAT-1000A ( POLQ )	HRD positive cancer More	Preclinical